CME Group vs Nasdaq
Nasdaq reported revenue of $8.3 billion in fiscal 2025, 1.3 times CME Group's $6.5 billion in fiscal 2025. CME Group's revenue grew 6.4% in its latest year, and Nasdaq's grew 11.7%. CME Group had an operating margin of 64.9%, against 28.2% at Nasdaq. Free cash flow was $4.2 billion at CME Group and $2.0 billion at Nasdaq.
Side by side
| CME Group | Nasdaq | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $6.5B | $8.3B |
| Revenue growth | 6.4% | 11.7% |
| Revenue growth a year, last 5 years | 6.0% | 8.0% |
| Gross margin | — | 63.5% |
| Operating margin | 64.9% | 28.2% |
| Net margin | 62.5% | 21.6% |
| Free cash flow | $4.2B | $2.0B |
| Free cash flow margin | 64.3% | 24.1% |
| Return on capital | 11.8% | 9.5% |
| Net debt to EBITDA | −0.3x | 3.4x |
| Dividends and buybacks | $3.9B | $1.2B |
| Change in diluted share count | 0.1% | −0.1% |
| Last close | $308.06 | $104.72 |
| P/E at the last close | 25.3× | 28.6× |
| Insider trades, last 12 months | bought $666,921, sold $30.2 million | bought $21.7 million, sold $87.0 million |
| Piotroski F-score | 7 of 8 | 9 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
CME GroupNasdaq
Operating margin
Percent of revenue
CME GroupNasdaq
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CME GroupNasdaq